Optical Genome Mapping Market Size, Trends and Insights By Product (Consumables, Services & Software, Instrument), By Application (Genome Assembly, Structural Variation Detection, Microbial Strain Typing, Haplotype Phasing, Others), By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033
Report Snapshot
| Study Period: | 2024-2033 |
| Fastest Growing Market: | Asia-Pacific |
| Largest Market: | Europe |
Major Players
- Bionano Genomics
- Illumina Inc.
- Oxford Nanopore Technologies
- Pacific Biosciences of California Inc.
- Agilent Technologies Inc.
- Others
Reports Description
Global Optical Genome Mapping Market was valued at USD 104.9 Million in 2023 and is expected to reach USD 329.2 Million by 2032, at a CAGR of 17.5% during the forecast period 2023 – 2032.
Optical genome mapping is a study of genomics technology that uses high-resolution images of particular DNA molecules to determine structural changes and genomic organization. Optical genome mapping gives significant insight into genomic structure and diversity, which aids in the study of hereditary illnesses, cancer genetics, biological evolution, and genome assembly.
Optical Genome Mapping Market: Growth Factors
Rising awareness among the population related to prenatal testing
The growing public awareness of prenatal testing is a crucial driver for the optical genome mapping industry. As people become more aware of the significance of prenatal screening in detecting genetic abnormalities and hereditary illnesses in unborn kids, there is an increasing need for improved technologies that provide complete and precise genomic analysis.
Because of its capacity to detect major structural alterations in the human genome with high resolution and sensitivity, optical genome mapping is an effective prenatal diagnostic method. This approach outperforms established methods such as karyotyping and fluorescence in situ hybridization by offering a more complete picture of the genome.
For instance, Bionano Genomics, Inc. announced the release of the second interim report from ongoing clinical research aimed at establishing OGM as the standard of care (SOC) in the identification of genetic illness in prenatal individuals. This paper describes the prenatal genetic disorder clinical trial program, which aims to test OGM as an alternative to SOC processes.
Increasing demand for advanced genomic analysis tools and techniques
The growing need for better genomic analysis tools and methodologies is a significant driver of the optical genome mapping industry. As academics and doctors seek more extensive and reliable ways of researching genes, optical genome mapping provides significant benefits.
Its capacity to directly see large-scale genomic structural variations closes a critical gap left by standard sequencing methods, which may overlook specific types of structural variants. Furthermore, optical genome mapping allows for quick, cost-effective, and scalable genome analysis, making it appealing for a variety of applications such as clinical diagnostics, customized healthcare, and industrial genomics.
The expanding acceptance of optical genome mapping in research facilities, academic institutions, and clinical settings underlines the necessity for strong genomic analytic tools capable of offering complete insights into genome structure.
For instance, a new genomic mapping technique may provide secrets for treating blood malignancies. Scientists have grown increasingly capable of detecting SVs as the next-generation genomic analysis technology and procedures have advanced. The team next utilized statistical analysis to compare the SVs in the optical genome mapping results to the outcomes from the drug sensitivity testing.
Optical Genome Mapping Market: Restraints
High cost of instrument and services
The high expense of instruments and services creates a substantial obstacle to entry for many potential optical genome mapping industry participants. The initial cost of obtaining the specialized equipment and infrastructure necessary for optical genome mapping might be prohibitively expensive for academic institutes, clinical laboratories, and smaller biotechnology enterprises.
Additionally, the fees related to consumables, maintenance levels, and technical support add to the total cost of implementing this technology. As a result, budget restrictions may discourage businesses from selecting optical genome mapping, restricting its widespread use and market penetration.
Furthermore, the high cost of services provided by organizations that offer optical genome mapping as a service may constitute a barrier for potential clients looking for low-cost genetic analysis solutions.
Optical Genome Mapping Market: Opportunities
Innovations in high-resolution imaging and data analysis algorithms
Innovations in high-resolution imaging, DNA tagging, and data processing techniques are propelling the optical genome mapping sector. High-resolution imaging technologies, such as improved microscopy and nanoimaging methods, allow for a clear and detailed image of individual DNA molecules, making structural alterations in the genome easier to identify.
Improved DNA labelling technologies, such as fluorescent colours and sequence-specific labels, increase the intensity and specificity of DNA molecules, allowing for more exact mapping of genomic characteristics.
Furthermore, advances in data analysis technologies, like as machine learning and bioinformatics tools, allow for the effective processing and interpretation of massive volumes of genomic data generated by optical genome mapping. These advancements cumulatively lead to the widespread use of optical genome mapping in a variety of domains, including clinical diagnostics, customized healthcare, and fundamental research.
For instance, according to Oxford research, DeepOM is a novel computer approach for optical genome mapping that makes use of deep learning. The use of convolutional neural networks that are trained on simulated pictures of tagged DNA molecules increases the success rate in aligning DNA images to genetic references.
OGM uses include pathogen detection in clinical samples and genome-wide mapping of impacts such as DNA damage and structural variation.
Optical Genome Mapping Market: Segmentation Analysis
The Global Optical Genome Mapping market is segmented by product, application, end user and region. Based on product, the market is classified into consumables, services & software and instruments. Services and software dominated the market in 2022 with a market share of 45% and is expected to keep its dominance during the forecast period 2024-2032.
Services and software are major drivers of the optical genome mapping business, improving the accessibility, efficiency, and understanding of genomic data produced by this technique. Sample preparation, data capture, and data analysis are examples of service solutions that give researchers simplified workflows and professional support, lowering the barrier to the adoption of optical genome mapping.
Furthermore, software technologies facilitate efficient data administration, visualization, and analysis allowing researchers to derive valuable insights from complicated genomic datasets. These software systems frequently include advanced algorithms for structural variant discovery, annotation, and comparative genomics, allowing researchers to find clinically relevant genomic changes and explain their functional consequences.
Furthermore, service providers and software developers are constantly innovating to improve the scalability, accuracy, and usability of optical genome mapping technology, boosting market expansion.
Based on application, the market is classified into genome assembly, structural variation detection, microbial strain typing, haplotype phasing and others. The structural variation detection segment dominated the market in 2022 with a market share of 45% and is expected to keep its dominance during the forecast period 2024-2032.
The discovery of structural variants (SVs) is a key driver of the optical genome mapping (OGM) sector. SVs, which comprise large-scale genomic rearrangements like as deletions, duplications, inversions, and translocations, are critical for understanding genetic disorders, cancer biology, and population variation. Optical genome mapping is a complementary method that involves photographing and examining individual DNA molecules at high resolution.
This method allows for thorough identification of SVs across the genome, including repetitive sections and complicated rearrangements, with fewer false positives and negatives. OGM has gained popularity in studies, medical diagnostics, and pharmaceutical industries, fuelling market expansion by meeting the unmet demand for robust and accurate SV detection in genomics.
Based on end users, the market is classified as biotechnology & pharmaceutical companies, academic & research institutions, and others. The biotechnology & pharmaceutical companies segment dominated the market in 2022 with a market share of 55% and is expected to keep its dominance during the forecast period 2024-2032.
Biotechnology and pharmaceutical firms are crucial in moving the optical genome mapping market ahead through a variety of channels. These businesses frequently have significant R&D resources committed to improving genomic technology.
Furthermore, biotech and pharmaceutical companies use optical genome mapping for a variety of purposes, including drug development, precision medicine, and biomarker identification.
Moreover, organizations frequently partner with technology vendors to develop solutions customized to their unique research or clinical needs, hence promoting further innovation and adoption of optical genome mapping technologies in both fundamental research.
Report Scope
| Feature of the Report | Details |
| Market Size in 2023 | USD 104.9 Million |
| Projected Market Size in 2032 | USD 329.2 Million |
| Market Size in 2022 | USD 94.5 Million |
| CAGR Growth Rate | 17.5% CAGR |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Key Segment | By Product, Application, End User and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Optical Genome Mapping Market: Regional Analysis
By region, Optical Genome Mapping market is segmented into North America, Europe, Asia-Pacific, Latin America, the Middle East & Africa. North America dominated the global Optical Genome Mapping market in 2022 with a market share of 40% in 2022 and is expected to keep its dominance during the forecast period 2024-2032.
North America drives the optical genome mapping industry through a variety of factors. To begin, the area is home to several renowned biotechnology and genomics businesses that research and commercialize cutting-edge technologies.
North America is home to world-renowned research organizations and colleges that are performing ground-breaking genomics and genetics research. Their desire for improved genetic analysis tools drives market expansion and acceptance.
Furthermore, coordinated cooperation across academia, business, and government programs encourages technological development and adoption. Furthermore, North America’s favourable regulatory framework and extensive healthcare infrastructure make optical genome mapping more easily integrated into clinical applications like diagnostics and customized therapy.
Overall, the North American ecosystem of research, innovation, and industry leadership work together to fuel the expansion of the optical genome mapping market in the region and globally.
Optical Genome Mapping Market: Recent Developments
- In November 2022, Nabsys, a genome analysis technology startup, aims to take another attempt at the whole-genome mapping industry, this time focused on the human genome and has secured an extra $13 million from Hitachi High-Technologies.
- In September 2020, Nucleome Informatics Private Limited announced the acquisition of South Asia’s first PacBio Sequel II system. With the most advanced bioinformatics setup, Nucleome Informatics is India’s fastest growing genomics startup.
- In December 2021, Cerba HealthCare, a global leader in medical diagnostics, announced that it has agreed to purchase Viroclinics-DDL, a rapidly developing global virology and immunology contract research organization (CRO) from Summit Partners.
List of the prominent players in the Optical Genome Mapping Market:
- Bionano Genomics
- Illumina Inc.
- Oxford Nanopore Technologies
- Pacific Biosciences of California Inc.
- Agilent Technologies Inc.
- Thermo Fisher Scientific Inc.
- Zymo Research Corp.
- Bio-Rad Laboratories Inc.
- PerkinElmer Inc.
- Roche Diagnostics
- 10X Genomics
- NanoString Technologies Inc.
- GenapSys Inc.
- Cytoscan Technologies Inc.
- Danaher Corporation
- Qiagen N.V.
- BGI Genomics Co. Ltd.
- Caris Life Sciences
- Exact Sciences Corporation
- Others
These key players are adopting various growth strategies such as mergers & acquisitions, joint ventures, expansion, strategic alliances, new product launches, etc. to enhance their business operations and revenues.
The Optical Genome Mapping Market is segmented as follows:
By Product
- Consumables
- Services & Software
- Instrument
By Application
- Genome Assembly
- Structural Variation Detection
- Microbial Strain Typing
- Haplotype Phasing
- Others
By End User
- Biotechnology & Pharmaceutical Companies
- Academic & Research Institutions
- Others
Regional Coverage:
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Taiwan
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market Research Methodology
- Chapter 2. Executive Summary
- 2.1 Global Optical Genome Mapping Market, (2024 – 2033) (USD Million)
- 2.2 Global Optical Genome Mapping Market: snapshot
- Chapter 3. Global Optical Genome Mapping Market – Industry Analysis
- 3.1 Optical Genome Mapping Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Rising awareness among the population related to prenatal testing
- 3.2.2 Rising awareness among the population related to prenatal testing
- 3.2.3 Increasing demand for advanced genomic analysis tools and techniques
- 3.3 Market Restraints
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End User
- Chapter 4. Global Optical Genome Mapping Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Optical Genome Mapping Market: Company Market Share, 2022
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, collaboration, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Optical Genome Mapping Market – Product Analysis
- 5.1 Global Optical Genome Mapping Market Overview: By Product
- 5.1.1 Global Optical Genome Mapping Market Share, By Product, 2022 and – 2033
- 5.2 Consumables
- 5.2.1 Global Optical Genome Mapping Market by Consumables, 2024 – 2033 (USD Million)
- 5.3 Services & Software
- 5.3.1 Global Optical Genome Mapping Market by Services & Software, 2024 – 2033 (USD Million)
- 5.4 Instrument
- 5.4.1 Global Optical Genome Mapping Market by Instrument, 2024 – 2033 (USD Million)
- 5.1 Global Optical Genome Mapping Market Overview: By Product
- Chapter 6. Global Optical Genome Mapping Market – Application Analysis
- 6.1 Global Optical Genome Mapping Market Overview: By Application
- 6.1.1 Global Optical Genome Mapping Market Share, By Application, 2022 and – 2033
- 6.2 Genome Assembly
- 6.2.1 Global Optical Genome Mapping Market by Genome Assembly, 2024 – 2033 (USD Million)
- 6.3 Structural Variation Detection
- 6.3.1 Global Optical Genome Mapping Market by Structural Variation Detection, 2024 – 2033 (USD Million)
- 6.4 Microbial Strain Typing
- 6.4.1 Global Optical Genome Mapping Market by Microbial Strain Typing, 2024 – 2033 (USD Million)
- 6.5 Haplotype Phasing
- 6.5.1 Global Optical Genome Mapping Market by Haplotype Phasing, 2024 – 2033 (USD Million)
- 6.6 Others
- 6.6.1 Global Optical Genome Mapping Market by Others, 2024 – 2033 (USD Million)
- 6.1 Global Optical Genome Mapping Market Overview: By Application
- Chapter 7. Global Optical Genome Mapping Market – End User Analysis
- 7.1 Global Optical Genome Mapping Market Overview: By End User
- 7.1.1 Global Optical Genome Mapping Market Share, By End User, 2022 and – 2033
- 7.2 Biotechnology & Pharmaceutical Companies
- 7.2.1 Global Optical Genome Mapping Market by Biotechnology & Pharmaceutical Companies, 2024 – 2033 (USD Million)
- 7.3 Academic & Research Institutions
- 7.3.1 Global Optical Genome Mapping Market by Academic & Research Institutions, 2024 – 2033 (USD Million)
- 7.4 Others
- 7.4.1 Global Optical Genome Mapping Market by Others, 2024 – 2033 (USD Million)
- 7.1 Global Optical Genome Mapping Market Overview: By End User
- Chapter 8. Optical Genome Mapping Market – Regional Analysis
- 8.1 Global Optical Genome Mapping Market Regional Overview
- 8.2 Global Optical Genome Mapping Market Share, by Region, 2022 & – 2033 (USD Million)
- 8.3. North America
- 8.3.1 North America Optical Genome Mapping Market, 2024 – 2033 (USD Million)
- 8.3.1.1 North America Optical Genome Mapping Market, by Country, 2024 – 2033 (USD Million)
- 8.3.1 North America Optical Genome Mapping Market, 2024 – 2033 (USD Million)
- 8.4 North America Optical Genome Mapping Market, by Product, 2024 – 2033
- 8.4.1 North America Optical Genome Mapping Market, by Product, 2024 – 2033 (USD Million)
- 8.5 North America Optical Genome Mapping Market, by Application, 2024 – 2033
- 8.5.1 North America Optical Genome Mapping Market, by Application, 2024 – 2033 (USD Million)
- 8.6 North America Optical Genome Mapping Market, by End User, 2024 – 2033
- 8.6.1 North America Optical Genome Mapping Market, by End User, 2024 – 2033 (USD Million)
- 8.7. Europe
- 8.7.1 Europe Optical Genome Mapping Market, 2024 – 2033 (USD Million)
- 8.7.1.1 Europe Optical Genome Mapping Market, by Country, 2024 – 2033 (USD Million)
- 8.7.1 Europe Optical Genome Mapping Market, 2024 – 2033 (USD Million)
- 8.8 Europe Optical Genome Mapping Market, by Product, 2024 – 2033
- 8.8.1 Europe Optical Genome Mapping Market, by Product, 2024 – 2033 (USD Million)
- 8.9 Europe Optical Genome Mapping Market, by Application, 2024 – 2033
- 8.9.1 Europe Optical Genome Mapping Market, by Application, 2024 – 2033 (USD Million)
- 8.10 Europe Optical Genome Mapping Market, by End User, 2024 – 2033
- 8.10.1 Europe Optical Genome Mapping Market, by End User, 2024 – 2033 (USD Million)
- 8.11. Asia Pacific
- 8.11.1 Asia Pacific Optical Genome Mapping Market, 2024 – 2033 (USD Million)
- 8.11.1.1 Asia Pacific Optical Genome Mapping Market, by Country, 2024 – 2033 (USD Million)
- 8.11.1 Asia Pacific Optical Genome Mapping Market, 2024 – 2033 (USD Million)
- 8.12 Asia Pacific Optical Genome Mapping Market, by Product, 2024 – 2033
- 8.12.1 Asia Pacific Optical Genome Mapping Market, by Product, 2024 – 2033 (USD Million)
- 8.13 Asia Pacific Optical Genome Mapping Market, by Application, 2024 – 2033
- 8.13.1 Asia Pacific Optical Genome Mapping Market, by Application, 2024 – 2033 (USD Million)
- 8.14 Asia Pacific Optical Genome Mapping Market, by End User, 2024 – 2033
- 8.14.1 Asia Pacific Optical Genome Mapping Market, by End User, 2024 – 2033 (USD Million)
- 8.15. Latin America
- 8.15.1 Latin America Optical Genome Mapping Market, 2024 – 2033 (USD Million)
- 8.15.1.1 Latin America Optical Genome Mapping Market, by Country, 2024 – 2033 (USD Million)
- 8.15.1 Latin America Optical Genome Mapping Market, 2024 – 2033 (USD Million)
- 8.16 Latin America Optical Genome Mapping Market, by Product, 2024 – 2033
- 8.16.1 Latin America Optical Genome Mapping Market, by Product, 2024 – 2033 (USD Million)
- 8.17 Latin America Optical Genome Mapping Market, by Application, 2024 – 2033
- 8.17.1 Latin America Optical Genome Mapping Market, by Application, 2024 – 2033 (USD Million)
- 8.18 Latin America Optical Genome Mapping Market, by End User, 2024 – 2033
- 8.18.1 Latin America Optical Genome Mapping Market, by End User, 2024 – 2033 (USD Million)
- 8.19. The Middle-East and Africa
- 8.19.1 The Middle-East and Africa Optical Genome Mapping Market, 2024 – 2033 (USD Million)
- 8.19.1.1 The Middle-East and Africa Optical Genome Mapping Market, by Country, 2024 – 2033 (USD Million)
- 8.19.1 The Middle-East and Africa Optical Genome Mapping Market, 2024 – 2033 (USD Million)
- 8.20 The Middle-East and Africa Optical Genome Mapping Market, by Product, 2024 – 2033
- 8.20.1 The Middle-East and Africa Optical Genome Mapping Market, by Product, 2024 – 2033 (USD Million)
- 8.21 The Middle-East and Africa Optical Genome Mapping Market, by Application, 2024 – 2033
- 8.21.1 The Middle-East and Africa Optical Genome Mapping Market, by Application, 2024 – 2033 (USD Million)
- 8.22 The Middle-East and Africa Optical Genome Mapping Market, by End User, 2024 – 2033
- 8.22.1 The Middle-East and Africa Optical Genome Mapping Market, by End User, 2024 – 2033 (USD Million)
- Chapter 9. Company Profiles
- 9.1 Bionano Genomics
- 9.1.1 Overview
- 9.1.2 Financials
- 9.1.3 Product Portfolio
- 9.1.4 Business Strategy
- 9.1.5 Recent Developments
- 9.2 Illumina Inc.
- 9.2.1 Overview
- 9.2.2 Financials
- 9.2.3 Product Portfolio
- 9.2.4 Business Strategy
- 9.2.5 Recent Developments
- 9.3 Oxford Nanopore Technologies
- 9.3.1 Overview
- 9.3.2 Financials
- 9.3.3 Product Portfolio
- 9.3.4 Business Strategy
- 9.3.5 Recent Developments
- 9.4 Pacific Biosciences of California Inc.
- 9.4.1 Overview
- 9.4.2 Financials
- 9.4.3 Product Portfolio
- 9.4.4 Business Strategy
- 9.4.5 Recent Developments
- 9.5 Agilent Technologies Inc.
- 9.5.1 Overview
- 9.5.2 Financials
- 9.5.3 Product Portfolio
- 9.5.4 Business Strategy
- 9.5.5 Recent Developments
- 9.6 Thermo Fisher Scientific Inc.
- 9.6.1 Overview
- 9.6.2 Financials
- 9.6.3 Product Portfolio
- 9.6.4 Business Strategy
- 9.6.5 Recent Developments
- 9.7 Zymo Research Corp.
- 9.7.1 Overview
- 9.7.2 Financials
- 9.7.3 Product Portfolio
- 9.7.4 Business Strategy
- 9.7.5 Recent Developments
- 9.8 Bio-Rad Laboratories Inc.
- 9.8.1 Overview
- 9.8.2 Financials
- 9.8.3 Product Portfolio
- 9.8.4 Business Strategy
- 9.8.5 Recent Developments
- 9.9 PerkinElmer Inc.
- 9.9.1 Overview
- 9.9.2 Financials
- 9.9.3 Product Portfolio
- 9.9.4 Business Strategy
- 9.9.5 Recent Developments
- 9.10 Roche Diagnostics
- 9.10.1 Overview
- 9.10.2 Financials
- 9.10.3 Product Portfolio
- 9.10.4 Business Strategy
- 9.10.5 Recent Developments
- 9.11 10X Genomics
- 9.11.1 Overview
- 9.11.2 Financials
- 9.11.3 Product Portfolio
- 9.11.4 Business Strategy
- 9.11.5 Recent Developments
- 9.13 NanoString Technologies Inc.
- 9.13.1 Overview
- 9.13.2 Financials
- 9.13.3 Product Portfolio
- 9.13.4 Business Strategy
- 9.13.5 Recent Developments
- 9.14 GenapSys Inc.
- 9.14.1 Overview
- 9.14.2 Financials
- 9.14.3 Product Portfolio
- 9.14.4 Business Strategy
- 9.14.5 Recent Developments
- 9.15 Cytoscan Technologies Inc.
- 9.15.1 Overview
- 9.15.2 Financials
- 9.15.3 Product Portfolio
- 9.15.4 Business Strategy
- 9.15.5 Recent Developments
- 9.16 Danaher Corporation
- 9.16.1 Overview
- 9.16.2 Financials
- 9.16.3 Product Portfolio
- 9.16.4 Business Strategy
- 9.16.5 Recent Developments
- 9.17 Qiagen N.V.
- 9.17.1 Overview
- 9.17.2 Financials
- 9.17.3 Product Portfolio
- 9.17.4 Business Strategy
- 9.17.5 Recent Developments
- 9.18 BGI Genomics Co. Ltd.
- 9.18.1 Overview
- 9.18.2 Financials
- 9.18.3 Product Portfolio
- 9.18.4 Business Strategy
- 9.18.5 Recent Developments
- 9.19 Caris Life Sciences
- 9.19.1 Overview
- 9.19.2 Financials
- 9.19.3 Product Portfolio
- 9.19.4 Business Strategy
- 9.19.5 Recent Developments
- 9.20 Exact Sciences Corporation
- 9.20.1 Overview
- 9.20.2 Financials
- 9.20.3 Product Portfolio
- 9.20.4 Business Strategy
- 9.20.5 Recent Developments
- 9.21 Others.
- 9.21.1 Overview
- 9.21.2 Financials
- 9.21.3 Product Portfolio
- 9.21.4 Business Strategy
- 9.21.5 Recent Developments
- 9.1 Bionano Genomics
List Of Figures
Figures No 1 to 27
List Of Tables
Tables No 1 to 77
Report Methodology
In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:
Preliminary Data Mining
On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.
Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.
Statistical Model
Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.
Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.
Some of the variables taken into account for forecasting are as follows:
• Industry drivers and constraints, as well as their current and projected impact
• The raw material case, as well as supply-versus-price trends
• Current volume and projected volume growth through 2032
We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.
Primary Validation
This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.
Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.
All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:
• Market leaders
• Suppliers of raw materials
• Suppliers of raw materials
• Buyers.
The following are the primary research objectives:
• To ensure the accuracy and acceptability of our data.
• Gaining an understanding of the current market and future projections.
Data Collection Matrix
| Perspective | Primary research | Secondary research |
| Supply-side |
|
|
| Demand-side |
|
|
Market Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|
|
Prominent Player
- Bionano Genomics
- Illumina Inc.
- Oxford Nanopore Technologies
- Pacific Biosciences of California Inc.
- Agilent Technologies Inc.
- Thermo Fisher Scientific Inc.
- Zymo Research Corp.
- Bio-Rad Laboratories Inc.
- PerkinElmer Inc.
- Roche Diagnostics
- 10X Genomics
- NanoString Technologies Inc.
- GenapSys Inc.
- Cytoscan Technologies Inc.
- Danaher Corporation
- Qiagen N.V.
- BGI Genomics Co. Ltd.
- Caris Life Sciences
- Exact Sciences Corporation
- Others
FAQs
The restraints of the Optical Genome Mapping market is high cost of instrument and services.
The major driver for the Optical Genome Mapping market is rising awareness among the population related to prenatal testing and increasing demand for advanced genomic analysis tools and techniques.
The “Consumables” category dominated the market in 2022.
The key players in the market are Bionano Genomics, Illumina Inc., Oxford Nanopore Technologies, Pacific Biosciences of California Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., Zymo Research Corp., Bio-Rad Laboratories Inc., PerkinElmer Inc., Roche Diagnostics, 10X Genomics, Bionano Genomics, NanoString Technologies Inc., GenapSys Inc., Cytoscan Technologies Inc., Danaher Corporation, Qiagen N.V., BGI Genomics Co. Ltd., Caris Life Sciences, Exact Sciences Corporation, Others.
“North America” had the largest share in the Optical Genome Mapping Market.
The global market is projected to grow at a CAGR of 17.5% during the forecast period, 2023-2032.
The Optical Genome Mapping Market size was valued at USD 104.9 Million in 2023.